$377.31
-2.99 (-0.786%)
At Close: Jul 31, 2026
Madison Mid Cap Fund Q2 2026 Portfolio Activity
09:49am, Friday, 31'st Jul 2026
The top five contributors for the quarter were MKS, Amphenol, Arista Networks, Bio-Techne, and Waters. The bottom five detractors for the quarter were Ross Stores, Arch Capital, Copart, Gartner, and B
Waters (WAT) Earnings Expected to Grow: Should You Buy?
11:06am, Tuesday, 28'th Jul 2026
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Waters (WAT) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Monday, 27'th Jul 2026
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer
08:10am, Monday, 27'th Jul 2026
Brings Xevo™ TQ Absolute XR Mass Spectrometer's industry-leading tandem quadrupole MS sensitivity to clinical applications across women's health, cancer assessment, and toxicology. Offers 5x greater
Assetmark Inc. Grows Stock Holdings in Waters Corporation $WAT
04:23am, Friday, 24'th Jul 2026
Assetmark Inc. lifted its holdings in Waters Corporation (NYSE: WAT) by 440.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The
Nestle to Offload Half of Waters Business in Joint Venture With Platinum Equity
01:34am, Thursday, 23'rd Jul 2026
The Swiss company agreed with Platinum Equity to create a joint venture and sell a 50% stake in its Waters and Beverages unit.
PitchBook Named Best Alternative Data Provider in Waters Technology Rankings 2026
09:00am, Friday, 17'th Jul 2026
SEATTLE--(BUSINESS WIRE)--PitchBook, a leading private capital market intelligence platform, today announced it has been named “Best Alternative Data Provider” in the Waters Technology Rankings 20
Waters Corporation Is Getting Awfully Pricey
11:48am, Tuesday, 14'th Jul 2026
Waters Corporation remains a Hold as valuation concerns are balanced by ongoing synergy capture from its Becton, Dickinson acquisition. WAT's Q1 pro forma sales rose to $1.54B, with legacy revenue up
Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
06:00am, Thursday, 02'nd Jul 2026
MILFORD, Mass., July 2, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m.
LONDON--(BUSINESS WIRE)--IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, and Waters Corporation (NYSE
Integrates heat flow, evolved gas, and electrochemical analysis in a single experiment, enabling earlier insights into thermal runaway. Unique whole-cell design eliminates cell teardown, reducing sam
Faster run times for GLP-1, insulin, and LNP drug substance testing accelerates biopharmaceutical development timelines and reduces production bottlenecks. Delivers up to 2x increase in resolving powe
Why Is Waters (WAT) Up 8.7% Since Last Earnings Report?
12:35pm, Thursday, 04'th Jun 2026
Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
04:02pm, Wednesday, 03'rd Jun 2026
Waters Corporation (WAT) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics
08:00am, Wednesday, 03'rd Jun 2026
FDA 510(k)-cleared BD BACTEC™ FXI Culture System now available to U.S. market, enabling broader access to confident bloodstream infection diagnostics. Achieves a 3-hour faster time to detection (~15
Sign In
Buy WAT